GLYCOM A/S
🏢 View company profile →93Patents
93Active
93Granted
55Portfolio score
Filing activity: Sep 24, 2008 → Nov 21, 2022 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11040050B2 | Composition comprising HMSs/HMOs and use thereof | Human Necessities | 5 | Active |
| US11040049B2 | Composition comprising HMSs/HMOs and use thereof | Human Necessities | 5 | Active |
| US11026959B2 | Synthetic composition and method for treating irritable bowel syndrome | Human Necessities | 4 | Active |
| US10828313B2 | Synthetic composition for treating metabolic disorders | Human Necessities | 3 | Active |
| US10751354B2 | Synthetic composition for microbiota modulation | Human Necessities | 3 | Active |
| US11278558B2 | Synthetic composition for microbiota modulation | Human Necessities | 3 | Active |
| US10835544B2 | Synthetic composition for regulating satiety | Human Necessities | 2 | Active |
| US9382564B2 | Diversification of human milk oligosaccharides (HMOs) or precursors thereof | Chemistry; Metallurgy | 2 | Active |
| US10780103B2 | Synthetic composition and method for modulating emotion and mood disorders | Human Necessities | 2 | Active |
| US10987368B2 | Synthetic composition for preventing or treating CVD | Human Necessities | 2 | Active |
| US10471084B2 | Composition and method for treating acute respiratory tract infections | Human Necessities | 2 | Active |
| US10857168B2 | Synthetic composition for microbiota modulation | Human Necessities | 2 | Active |
| US10864224B2 | Synthetic composition for treating antibiotic associated complications | Emerging Cross-Sectional Technologies | 2 | Active |
| US8993740B2 | Method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnt) containing N-acetyllactosamine | Human Necessities | 1 | Active |
| US11608504B2 | Nucleic acid construct for in vitro and in vivo gene expression | Chemistry; Metallurgy | 1 | Active |
| US11696921B2 | Synthetic composition for microbiota modulation | Human Necessities | 1 | Active |
| US10588917B2 | Mixtures of human milk oligosaccharides comprising 3 ′-O-sialyllactose | Chemistry; Metallurgy | 1 | Active |
| US10696705B2 | Crystalline forms of LNT | Chemistry; Metallurgy | 1 | Active |
| US10881674B2 | Synthetic composition for treating metabolic disorders | Human Necessities | 1 | Active |
| US10428318B2 | Mutated sialidases | Chemistry; Metallurgy | 1 | Active |
| US11224605B2 | Synthetic composition | Human Necessities | 1 | Active |
| US11529365B2 | Synthetic composition for microbiota modulation | Human Necessities | 1 | Active |
| US11293042B2 | Oligosaccharide production | Chemistry; Metallurgy | 1 | Active |
| US10407516B2 | Crystalline HMO | Human Necessities | 1 | Active |
| US10314852B2 | Mixtures of HMOs | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.